Will GPs prescribe the new ‘COVID-19 pill’?
The Federal Government has ordered 300,000 doses of molnupiravir on the condition it obtains TGA approval
Australia is buying 300,000 courses of a new antiviral pill to treat COVID-19 that could become the first early-stage treatment option for GPs.
The drug, molnupiravir, is still under TGA review and not expected to arrive in Australia — if it is approved — until next year.
